Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Pfizer kind of operates like the aliens from Independence Day: they’re like locusts. They’re moving from pharma to pharma… their whole organization. After they’ve consumed every natural resource they move on… and Wyeth’s next.
2 comments:
Anonymous
said...
He gets over $21 million in both cash and stock as payment from Wyeth for 3 separate positions he holds...I wonder how he's going to like the taxes on ALL of it when the merger goes through - after all - he's for the merger! (He probably doesn't care, because he's already slated to become a Pfizer board member.....) Anyone want to guess about his new salary at Pfizer.....? Shareholders are extremely angry seeing the truth about his earnings and other board members earings in print.
So the deal let's Pfizer dilute the impact of Lipitor going off patent and gives them the BioPharm and Vaccine treasure chest and the Comsumer brands and Nutritional cash cows. Good for them. So tell me again what it did for WYETH? Shareholder value? A tsunami to the employees. It's a windfall of greed for the exec committee. Ran away from the failure of R&D to come up with any meaningful drug prospects. It's a pipeline of me-too line extentions (how long for Pfizer to figure that out?). Let's at least hope Bernard spends his millions in the US and not France. Phailed is RIGHT!
2 comments:
He gets over $21 million in both cash and stock as payment from Wyeth for 3 separate positions he holds...I wonder how he's going to like the taxes on ALL of it when the merger goes through - after all - he's for the merger! (He probably doesn't care, because he's already slated to become a Pfizer board member.....) Anyone want to guess about his new salary at Pfizer.....? Shareholders are extremely angry seeing the truth about his earnings and other board members earings in print.
So the deal let's Pfizer dilute the impact of Lipitor going off patent and gives them the BioPharm and Vaccine treasure chest and the Comsumer brands and Nutritional cash cows. Good for them. So tell me again what it did for WYETH? Shareholder value? A tsunami to the employees. It's a windfall of greed for the exec committee. Ran away from the failure of R&D to come up with any meaningful drug prospects. It's a pipeline of me-too line extentions (how long for Pfizer to figure that out?). Let's at least hope Bernard spends his millions in the US and not France. Phailed is RIGHT!
Post a Comment